Healthy men needed to track how new kidney drug leaves the body
NCT ID NCT07557407
First seen Apr 30, 2026 · Last updated Apr 30, 2026
Summary
This study will give a single dose of a radioactive-labeled drug called HRS-1780 to 6 healthy men. Researchers will measure how the drug is absorbed, broken down, and removed in urine and stool. The goal is to understand the drug's path through the body, not to treat any disease. Participants must be healthy males aged 18-45 with a BMI between 19 and 26.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jinan Central Hospital, Affiliated to Shandong First Medical University
Jinan, Shandong, 250013, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.